ClinicalTrials.gov
ClinicalTrials.gov Menu

Frailty Assessment in Elderly Patients With Acute Coronary Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03365505
Recruitment Status : Not yet recruiting
First Posted : December 7, 2017
Last Update Posted : December 7, 2017
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center

Brief Summary:

Frailty is known as an independent risk factor for morbidity and mortality in older cardiac patients . It is an important factor on the cardiologist decision between conservative and invasive treatment in older patient with acute coronary syndrome, and is usually made subjectively by the cardiologist known in the literature as eyeball testing.

in this study the investigators will compare the cardiologists eye ball testing to objective frailty assessment based on Fried score and Edmonton frailty scale.


Condition or disease
Frail Elderly Syndrome Acute Coronary Syndrome

Detailed Description:

elderly patients admitted to Meir hospital with acute coronary syndrome will be assessed for frailty twice: the first frailty assessment will be a subjective eye ball testing made by the cardiologist, the second assessment will be an objective one based on Fried frailty score and Edmonton frail scale.

The cardiologist will not be aware of the objective frailty assessment result.

The eye ball testing will be compared to the objective frailty assessment (Fried score and Edmonton frailty scale).


Study Type : Observational [Patient Registry]
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Year
Official Title: Frailty Assessment in Elderly Patients With Acute Coronary Syndrome
Estimated Study Start Date : December 15, 2017
Estimated Primary Completion Date : September 15, 2018
Estimated Study Completion Date : September 15, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Checkup




Primary Outcome Measures :
  1. A subjective eye ball frailty assessment will be compared to an objective frailty assessment based on Fried score and Edmonton frailty scale [ Time Frame: Through hospitalization , an average of 1 week ]
    Subjective frailty assessment made by a cardiologist during hospitalization with acute coronary syndrome- "eye ball" testing

  2. An objective frailty assessment using Fried score and Edmonton frailty scale will be compared to a subjective eye ball frailty assessment [ Time Frame: Through hospitalization , an average of 1 week ]
    An objective frailty assessment based on Fried score and Edmonton frailty scale



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   80 Years to 120 Years   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
elderly patient admitted to our hospital with acute coronary syndrome: unstable angina or non ST elevation myocardial infarction who are aged 80 and above and are hemodinamically stable.
Criteria

Inclusion Criteria:

  • patient admitted to Meir hospital with acute coronary syndrome
  • Age: 80 years old and older
  • eligible for signing an informed concent

Exclusion Criteria:

  • uncontrolled heart failure ( pulmonary edema or the use of iv diuretics)
  • cardiogenic shock
  • fever st elevation myocardial infarction

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT03365505     History of Changes
Other Study ID Numbers: 00-34-17-MMC
First Posted: December 7, 2017    Key Record Dates
Last Update Posted: December 7, 2017
Last Verified: December 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Syndrome
Acute Coronary Syndrome
Disease
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases